Category: Corona Virus

Page 31«..1020..30313233..4050..»

COVID-19 whistleblower’s status unknown after 4-year prison term – Yahoo! Voices

May 15, 2024

[Source]

Chinese citizen journalist Zhang Zhan was expected to be released on May 13 after spending four years behind bars for documenting the early days of the COVID-19 outbreak, but her current status remains unknown.

Key points:

Zhang's videos documented crowded hospitals, empty streets and interviews with Wuhan residents in lockdown.

Her content countered the Chinese government's official narrative of how it was handling the coronavirus outbreak.

Detained in May 2020, she was charged with the vague offense of "picking quarrels and provoking trouble."

Reports of hunger strikes, force-feeding and a dramatic weight loss during her imprisonment sparked concerns about Zhang's health over the years.

The details:

Trending on NextShark: New documentary remembers how incarcerated Japanese Americans lived in WWII

Zhang, a former lawyer, traveled from Shanghai to Wuhan to document events as COVID-19 took over the city in early 2020. She posted unfiltered reports on Chinese social media, as well as YouTube, which is banned in China.

Her reports, which offered a rare glimpse into the early extent of the outbreak, eventually gained traction. She also wrote essays critical of the Chinese government response.

Zhang's family and rights groups were expecting her release on May 13 based on a court verdict they obtained. But as of Monday evening, advocates lamented that there had been no confirmation whether she was able to walk free.

Activist Jane Wang, who heads the U.K.-based Free Zhang Zhan campaign, expressed concerns about Zhang's condition.

Zhang Zhan should have regained her freedom. We should have heard from her or her family by now. Instead, we are left wondering where she is, how she is doing physically and mentally, whats happened to her family and what the future holds for her:

Zhang's family has reportedly faced pressure from authorities to remain silent, adding to the uncertainty surrounding her situation.

Trending on NextShark: COVID-19 whistleblower's status unknown after 4-year prison term

Download the NextShark App:

Want to keep up to date on Asian American News? Download the NextShark App today!

Read more here:

COVID-19 whistleblower's status unknown after 4-year prison term - Yahoo! Voices

Finding the chink in coronavirus’s armorexperiment reveals how the main protease of SARS-CoV-2 protects itself – Phys.org

May 15, 2024

This article has been reviewed according to ScienceX's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

proofread

by Gerhard Samulat , European XFEL

close

The COVID-19 pandemic resulted in millions of deaths. Despite an unparalleled collaborative research effort that led to effective vaccines and therapies being produced in record-breaking time, a complete understanding of the structure and lifecycle of the coronavirus known as SARS-CoV-2 is still lacking.

Scientists used the biolabs and the SPB/SFX instrument at the European XFEL to study the main protease, or Mpro, of the virus to understand how it protects itself from oxidative damage. The results add key knowledge to our understanding of the workings of SARS-CoV-2 and the field of viral biology.

The paper is published in the journal Nature Communications.

Between January 2020 and March 2023, over six million people died as a result of the respiratory disease COVID-19, and several hundred million were infected. The disease is caused by SARS-CoV-2, a coronavirus.

"Coronaviruses are a group of RNA viruses that cause illnesses and diseases in mammals and birds," explains European XFEL scientist Richard Bean. "However, despite their significant relevance for global human health, there is still a lot to learn about the structure and function of coronaviruses in general and SARS-CoV-2 in particular."

In response to the outbreak of the pandemic, scientists and scientific organizations around the globe poured efforts into studying the structure, dynamics, and function of SARS-CoV-2 in search of vaccines and therapies. Due to its central role in the replication cycle of the virus, the main proteasean enzyme that liberates newly made pieces of the virus from one anothersoon emerged as a key antiviral drug target.

The main protease, or Mpro, is particularly attractive for drug development because it plays a central role in viral replication, and also because it is quite different from all human proteins. This allows therapies to specifically target the virus while minimizing side effects that might harm patients. Previous drug discovery programs targeting other viruses have succeeded using viral protease inhibitors, making a successful outcome in the case of SARS-CoV-2 more likely.

"While the height of the COVID-19 pandemic may have passed, there is still a lot of value in studying the SARS-CoV-2 virus," says Thomas Lane from the Center for Free-Electron Laser Science (CFEL) in Hamburg. "COVID continues to present a significant health threat worldwide. Given the persistence of this virus and the possible emergence of future pathogenic coronaviruses, it is imperative we develop a deeper understanding of Mpro and its role in viral function."

In a recent experiment at the SPB/SFX instrument at the European XFEL, Lane and colleagues used the intense X-ray beam to study Mpro. Several previous structural studies focusing on Mpro have highlighted a number of peculiarities.

"Firstly, the protein forms a 3D structure known as a dimer when it is found in high concentrations," explains European XFEL scientist Robin Schubert, who was involved in the experiment. "This structural habit seems to directly influence its activitybut we don't know precisely why this is important for the virus." Alongside key insights into the 3D structure, recent studies have also hinted at the importance of cellular oxygen levels for protease activity.

"It seems that even mild exposure to oxygen decreases Mpro's activity," explains Patrick Reinke, also from CFEL. Indeed, in the presence of sufficient oxygen, turnover ceases altogether. But this process is reversibleif the oxygen is removed, the enzyme reactivates itself, suggesting the system has evolved protective mechanisms to survive in an oxidative environment.

"Oxidative stress has been shown to regulate the function of other viruses, such as HIV," Reinke adds. "It has been suggested that structural changes in the protease let it escape oxidative damage in oxygen-rich environments. However, we're still unsure of how these protective mechanisms impact viral fitness."

To better understand how structural changes protect the protein from oxygen damage, the team used the European XFEL's powerful X-ray beam to reveal the structure of Mpro after it had been exposed to oxygen. They discovered a structural rearrangement of Mpro in which a bond forms between two cysteine residues: the active site cysteine C145 and a distal cysteine C117.

To accomplish this, the team produced large amounts of Mpro over the course of several months in the biolabs at European XFEL and turned it into microcrystals, some of which were grown in the presence of oxygen. Finally, the microcrystals were sent flying in front of the European XFEL beam at the SPB/SFX instrument using a liquid jet.

Such small crystals are impossible to study using traditional light sources because the amount of radiation needed to generate enough data from the crystals would destroy them. The X-rays pulses produced by the European XFEL, however, are so powerful and short that they can be used to capture an image of the protein crystal before it has time to disintegrate.

"Our results show that the active site cysteine, which conducts the enzyme's chemistry, can sneakily hide itself from oxidative damage," says Schubert. Typically, oxidation can irreversibly damage cysteines.

Upon oxidation, however, Mpro protects its most important cysteine by forming what is known as a "disulfide bond," which buries it in the core of the protein structure. Then, if moved back into a safe, low-oxygen environment, the disulfide bond can break, revealing the active cysteine, which resumes its original function.

"The experiments performed at the European XFEL reveal a picture of the protein in its hidden disulfide state, confirming it exists and uncovering how it works," says Schubert.

"Mpro exhibits an unusually rich set of oxidation modifications, and our experiment adds a key piece to that story," says Lane. The scientists are excited about what their data indicate and about their next steps. "Mpro is a linchpin of coronavirus biology and the premier target for anti-COVID-19 small-molecule therapeutics.

"The enzyme's function has been shown to be regulated via both dimerization and oxidation, and it's clear that these regulatory mechanisms are biophysically correlated. While our structures provide mechanistic insight into these properties of Mpro, we must now understand how regulation based on oxidative stress or protein concentration impact viral fitness. This will provide deeper insight into viral biology and hopefully open new opportunities to disrupt that biology with life-preserving medicines."

More information: Patrick Y. A. Reinke et al, SARS-CoV-2 Mpro responds to oxidation by forming disulfide and NOS/SONOS bonds, Nature Communications (2024). DOI: 10.1038/s41467-024-48109-3

Journal information: Nature Communications

Provided by European XFEL

Read the rest here:

Finding the chink in coronavirus's armorexperiment reveals how the main protease of SARS-CoV-2 protects itself - Phys.org

Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19? – Globalization … – Globalization and Health

May 15, 2024

Background of the selected articles

The current study selected 58 articles for the SLR. Five themes were developed based on the thematic analysis from the predetermined research questions: the link between solar activity and pandemic outbreaks, regional area, climate and weather, the relationship between temperature and humidity, and government disinfection action guidelines. Among the articles retrieved between 2000 and 2022; two were published in 2010, one in 2011, four in 2013, three in 2014, two in 2015, six in 2016 and 2017, respectively, one in 2018, six in 2019, twelve in 2020, eight in 2021, and seven in 2022.

Numerous scientists have investigated the relationship between solar activities and pandemic outbreaks over the years ([43]; A [27, 44, 45].). Nuclear fusions from solar activities have resulted in minimum and maximum solar sunspots. Maximum solar activities are characterised by a high number of sunspots and elevated solar flare frequency and coronal mass injections. Minimum solar sunspot occurrences are identified by low interplanetary magnetic field values entering the earth [1].

A diminished magnetic field was suggested to be conducive for viruses and bacteria to mutate, hence the onset of pandemics. Nonetheless, Hoyle and Wickramasinghe [46] reported that the link between solar activity and pandemic outbreaks is only speculative. The literature noted that the data recorded between 1930 and 1970 demonstrated that virus transmissions and pandemic occurrences were coincidental. Moreover, no pandemic cases were reported in 1979, when minimum solar activity was recorded [47].

Chandra Wickramasinghe et al. [48] suggested a significant relationship between pandemic outbreaks and solar activities as several grand solar minima, including Sporer (14501550AD), Mounder (16501700AD), and Dalton (18001830) minimums, were recorded coinciding with global pandemics of diseases, such as smallpox, the English sweat, plague, and cholera pandemics. Furthermore, since the Dalton minimum, which recorded minimum sunspots, studies from 2002 to 2015 have documented the reappearance of previous pandemics. For example, influenza subtype H1N1 1918/1919 episodically returned in 2009, especially in India, China, and other Asian countries. Zika virus, which first appeared in 1950, flared and became endemic in 2015, transmitted sporadically, specifically in African countries. Similarly, SARS-CoV was first recorded in China in 2002 and emerged as an outbreak, MERS-CoV, in middle east countries a decade later, in 2012.

In 2020, the World Data Centre Sunspot Index and Long-term Solar Observations (http://sidc.be) confirmed that a new solar activity was initiated in December 2019, during which a novel coronavirus pandemic also occurred, and present a same as the previous hypothesis. Nevertheless, a higher number of pandemic outbreaks were documented during low minimum solar activities, including Ebola (1976), H5N1 (Nipah) (19671968), H1N1 (2009), and COVID-19 (2019current). Furthermore, Wickramasinghe and Qu [49] reported that since 1918 or 1919, more devastating and recurrent pandemics tend to occur, particularly after a century. Consequently, within 100years, a sudden surge of influenza was recorded, and novel influenza was hypothesised to emerge.

Figure4 demonstrates that low minimum solar activity significantly reduced before 2020, hence substantiating the claim that pandemic events are closely related to solar activities. Moreover, numerous studies (i.e. [43], Chandra [46,47,48]) reported that during solar minimums, new viruses could penetrate the surfaces of the earth and high solar radiation would result in lower infection rates, supporting the hypothesis mentioned above.

The number of sunspots in the last 13years. Note: The yellow curve indicates the daily sunspot number and the 20102021 delineated curve illustrates the minimum solar activity recorded (source: http://sidc.be/silso)

In early December 2019, Wuhan, China, was reported as the centre of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak [50]. Chinese health authorities immediately investigated and controlled the spread of the disease. Nevertheless, by late January 2020, the WHO announced that COVID-19 was a global public health emergency. The upgrade was due to the rapid rise in confirmed cases, which were no longer limited to Wuhan [28]. The disease had spread to 24 other countries, which were mainly in the northern hemisphere, particularly the European and Western Pacific regions, such as France, United Kingdom, Spain, South Korea, Japan, Malaysia, and Indonesia [51, 52]. The migration or movement of humans was the leading agent in the spread of COVID-19, resulting in an almost worldwide COVID-19 pandemic [53].

The first hotspots of the epidemic outspread introduced by the Asian and Western Pacific regions possessed similar winter climates with an average temperature and humidity rate of 511C and 4779%. Consequently, several publications reviewed in the current study associated the COVID-19 outbreak with regional climates (i.e. [1, 29, 54, 55]) instead of its close connection to China. This review also discussed the effects of a range of specific climatological variables on the transmission and epidemiology of COVID-19 in regional climatic conditions.

America and Europe documented the highest COVID-19 cases, outnumbering the number reported in Asia [19] and on the 2nd of December 2020, the United States of America (USA) reported the highest number of confirmed COVID-19 infections, with over 13,234,551 cases and 264,808 mortalities (DaS [56].). The cases in the USA began emerging in March 2020 and peaked in late November 2020, during the wintertime in the northern hemisphere (December to March) [53]. Figure5 demonstrates the evolution of the COVID-19 pandemic in several country which represent comparison two phase of summer and one phase of winter. Most of these countries tend to increase of COVID cases close to winter season. Then, it can be worsening on phase two of summer due to do not under control of human movement although the normal trend it is presenting during winter phase.

The evolution of the COVID-19 pandemic from the 15th of February 2020 to the 2nd of December 2020 (Source: https://www.worldometers.info/coronavirus)

The coronavirus spread aggressively across the European region, which recorded the second highest COVID-19 confirmed cases after America. At the end of 2020, WHO reported 19,071,275 Covid-19 cases in the area, where France documented 2,183,275 cases, the European country with the highest number of confirmed cases, followed by the United Kingdom (1,629,661 cases) and Spain (1,652,801 cases) [19]. Europe is also located in the northern hemisphere and possesses a temperate climate.

The spatial and temporal transmission patterns of coronavirus infection in the European region were similar to America and the Eastern Mediterranean, where the winter season increased COVID-19 cases. Typically, winter in Europe occurs at the beginning of October and ends in March. Hardy et al. [57] also stated that temperature commonly drops below freezing (approximately 1C) when snow accumulates between December to mid-March, resulting in an extreme environment. Figure 5 indicates that COVID-19 cases peaked in October when the temperature became colder [21]. Similarly, the cases were the highest in the middle of the year in Australia and South Asian countries, such as India, that experience winter and monsoon, respectively, during the period.

In African regions, the outbreak of COVID-19 escalated rapidly from June to October before falling from October to March, as summer in South Africa generally occurs from November to March, while winter from June to August. Nevertheless, heavy rainfall generally transpires during summer, hence the warm and humid conditions in South Africa and Namibia during summer, while the opposite happens during winter (cold and dry). Consequently, the outbreak in the region recorded an increasing trend during winter and subsided during the summer, supporting the report by Gunthe et al. [58]. Novel coronavirus disease presents unique and grave challenges in Africa, as it has for the rest of the world. However, the infrastructure and resources have limitations for Africa countries facing COVID-19 pandemic and the threat of other diseases [59].

Conclusively, seasonal and regional climate patterns were associated with COVID-19 outbreaks globally. According to Kraemer et al. [60], they used real-time mobility data in Wuhan and early measurement presented a positive correlation between human mobility and spread of COVID-19 cases. However, after the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases were still indicative of local chains of transmission outside of Wuhan.

The term weather represents the changes in the environment that occur daily and in a short period, while climate is defined as atmospheric changes happening over a long time (over 3 months) in specific regions. Consequently, different locations would experience varying climates. Numerous reports suggested climate and weather variabilities as the main drivers that sped or slowed the transmission of SARS-CoV-2 worldwide [44, 61,62,63].

From a meteorological perspective, a favourable environment has led to the continued existence of the COVID-19 virus in the atmosphere [64]. Studies demonstrated that various meteorological conditions, such as the rate of relative humidity (i.e. [28]), precipitation (i.e. [65]), temperature (i.e. [66]), and wind speed factors (i.e. [54]), were the crucial components that contributed to the dynamic response of the pandemic, influencing either the mitigation or exacerbation of novel coronavirus transmission. In other words, the environment was considered the medium for spreading the disease when other health considerations were put aside. Consequently, new opinions, knowledge, and findings are published and shared to increase awareness, thus encouraging preventive measures within the public.

The coronavirus could survive in temperatures under 30C with a relative humidity of less than 80% [67], suggesting that high temperatures and lower relative humidity contributed to the elicitation of COVID-19 cases [18, 51, 58, 68]. Lagtayi et al. [7] highlighted temperature as a critical factor, evidently from the increased transmission rate of MERS-Cov in African states with a warm and dry climate. Similarly, the highest COVID-19 cases were recorded in dry temperate regions, especially in western Europe (France and Spain), China, and the USA, while the countries nearer to the equator were less affected. Nevertheless, the temperature factor relative to viral infections depends on the protein available in the viruses. According to Chen and Shakhnovich [69], there is a good correlation between decreasing temperature and the growth of proteins in virus. Consequently, preventive measures that take advantage of conducive environments for specific viruses are challenging.

Precipitation also correlates with influenza [43]. A report demonstrated that regions with at least 150mm of monthly precipitation threshold level experienced fewer cases than regions with lower precipitation rates. According to Martins et al. [70], influenza and COVID-19 can be affected by climate, where virus can be spread through the respiratory especially during rainfall season. The daily spread of Covid-19 cases in tropical countries, which receive high precipitation levels, are far less than in temperate countries [27]. Likewise, high cases of COVID-19 were reported during the monsoon season (mid-year) in India during which high rainfall is recorded [71]. Moreover, the majority of the population in these regions has lower vitamin D levels, which may contribute to weakened immune responses during certain seasons [27].

Rainfall increases the relative atmospheric humidity, which is unfavourable to the coronaviruses as its transmission requires dry and cold weather. Moreover, several reports hypothesised that rain could wash away viruses on object surfaces, which is still questioned. Most people prefer staying home on rainy days, allowing less transmission or close contact. Conversely, [72] exhibited that precipitation did not significantly impact COVID-19 infectiousness in Oslo, Norway due the location in northern hemisphere which are during winter season presenting so cold.

Cokun et al. [54] and Wu et al. [29] claimed that wind could strongly correlate with the rate of COVID-19 transmission. Atmospheric instability (turbulent occurrences) leads to increased wind speed and reduces the dispersion of particulate matter (PM2.5 and PM10) in the environment and among humans. An investigation performed in 55 cities in Italy during the COVID-19 outbreak proved that the areas with low wind movement (stable atmospheric conditions) possessed a higher correlation coefficient and exceeded the threshold value of the safe level of PM2.5 and PM10. Resultantly, more individuals were recorded infected with the disease in the regions. As mentioned in Martins et al. [70] the COVID-19 can be affected by climate and the virus can be spread through respiratory which is the virus moving in the wind movement.

Climatic parameters, such as temperature and humidity, were investigated as the crucial factors in the epidemiology of the respiratory virus survival and transmission of COVID-19 ([61]; S [73, 74].). The rising number of confirmed cases indicated the strong transmission ability of COVID-19 and was related to meteorological parameters. Furthermore, several studies found that the disease transmission was associated with the temperature and humidity of the environment [55, 64, 68, 75], while other investigations have examined and reviewed environmental factors that could influence the epidemiological aspects of Covid-19.

Generally, increased COVID-19 cases and deaths corresponded with temperature, humidity, and viral transmission and mortality. Various studies reported that colder and dryer environments favoured COVID-19 epidemiologically [45, 76, 77]. As example tropical region, the observations indicated that the summer (middle of year) and rainy seasons (end of the year) could effectively diminish the transmission and mortality from COVID-19. High precipitation statistically increases relative air humidity, which is unfavourable for the survival of coronavirus, which prefers dry and cold conditions [32, 34, 78, 79]. Consequently, warmer conditions could reduce COVID-19 transmission. A 1C increase in the temperature recorded a decrease in confirmed cases by 8% increase [45].

Several reports established that the minimum, maximum, and average temperature and humidity correlated with COVID-19 occurrence and mortality [55, 80, 81]. The lowest and highest temperatures of 24 and 27.3C and a humidity between 76 and 91% were conducive to spreading the virulence agents. The propagation of the disease peaked at the average temperature of 26C and humidity of 55% before gradually decreasing with elevated temperature and humidity [78].

Researchers are still divided on the effects of temperature and humidity on coronavirus transmission. Xu et al. [26] confirmed that COVID-19 cases gradually increased with higher temperature and lower humidity, indicating that the virus was actively transmitted in warm and dry conditions. Nevertheless, several reports stated that the spread of COVID-19 was negatively correlated with temperature and humidity [10, 29, 63]. The conflicting findings require further investigation. Moreover, other factors, such as population density, elderly population, cultural aspects, and health interventions, might potentially influence the epidemiology of the disease and necessitate research.

The COVID-19 is a severe health threat that is still spreading worldwide. The epidemiology of the SAR-CoV-2 virus might be affected by several factors, including meteorological conditions (temperature and humidity), population density, and healthcare quality, that permit it to spread rapidly [16, 17]. Nevertheless, in 2020, no effective pharmaceutical interventions or vaccines were available for the diagnosis, treatment, and epidemic prevention against COVID-19 [73, 82]. Consequently, after 2020 the governments globally have designed and executed non-pharmacological public health measures, such as lockdown, travel bans, social distancing, quarantine, public place closure, and public health actions, to curb the spread of COVID-19 infections and several studies have reported on the effects of these plans [13, 83].

The COVID-19 is mainly spread via respiratory droplets from an infected persons mouth or nose to another in close contact [84]. Accordingly, WHO and most governments worldwide have recommended wearing facemasks in public areas to curb the transmission of COVID-19. The facemasks would prevent individuals from breathing COVID-19-contaminated air [85]. Furthermore, the masks could hinder the transmission of the virus from an infected person as the exhaled air is trapped in droplets collected on the masks, suspending it in the atmosphere for longer. The WHO also recommended adopting a proper hand hygiene routine to prevent transmission and employing protective equipment, such as gloves and body covers, especially for health workers [86].

Besides wearing protective equipment, social distancing was also employed to control the Covid-19 outbreak [74, 87]. Social distancing hinders the human-to-human transmission of the coronavirus in the form of droplets from the mouth and nose, as evidenced by the report from Sun and Zhai [88]. Conversely, Nair & Selvaraj [89] demonstrated that social distancing was less effective in communities and cultures where gatherings are the norm. Nonetheless, the issue could be addressed by educating the public and implementing social distancing policies, such as working from home and any form of plague treatment.

Infected persons, individuals who had contact with confirmed or suspected COVID-19 patients, and persons living in areas with high transmission rates were recommended to undergo quarantine by WHO. The quarantine could be implemented voluntarily or legally enforced by authorities and applicable to individuals, groups, or communities (community containment) [90]. A person under mandatory quarantine must stay in a place for a recommended 14-day period, based on the estimated incubation period of the SARS-CoV-2 [19, 91]. According to Stasi et al. [92], 14-days period for mandatory quarantine it is presenting a clinical improvement after they found 5-day group and 10-day group can be decrease number of patient whose getting effect of COVID-19 from 64 to 54% respectively. This also proven by Ahmadi et al. [43] and Foad et al. [93], quarantining could reduce the transmission of COVID-19.

Lockdown and travel bans, especially in China, the centre of the coronavirus outbreak, reduced the infection rate and the correlation of domestic air traffic with COVID-19 cases [17]. The observations were supported by Sun & Zhai [88] and Sun et al. [94], who noted that travel restrictions diminished the number of COVID-19 reports by 75.70% compared to baseline scenarios without restrictions. Furthermore, example in Malaysia, lockdowns improved the air quality of polluted areas especially in primarily at main cities [95]. As additional, Martins et al. [70] measure the Human Development Index (HDI) with the specific of socio-economic variables as income, education and health. In their study, the income and education levels are the main relevant factors that affect the socio-economic.

A mandatory lockdown is an area under movement control as a preventive measure to stop the coronavirus from spreading to other areas. Numerous governments worldwide enforced the policy to restrict public movements outside their homes during the pandemic. Resultantly, human-to-human transmission of the virus was effectively reduced. The lockdown and movement control order were also suggested for individuals aged 80 and above or with low or compromised immunities, as these groups possess a higher risk of contracting the disease [44].

Governments still enforced movement orders even after the introduction of vaccines by Pfizer, Moderna, and Sinovac, as the vaccines only protect high-risk individuals from the worst effects of COVID-19. Consequently, in most countries, after receiving the first vaccine dose, individuals were allowed to resume life as normal but were still required to follow the standard operating procedures (SOP) outlined by the government.

The government attempted to balance preventing COVID-19 spread and recovering economic activities, for example, local businesses, maritime traders, shipping activities, oil and gas production and economic trades [22, 96]. Nonetheless, the COVID-19 cases demonstrated an increasing trend during the summer due to the higher number of people travelling and on vacation, primarily to alleviate stress from lockdowns. Several new variants were discovered, including the Delta and Omicron strains, which spread in countries such as the USA and the United Kingdom. The high number of COVID-19 cases prompted the WHO to suggest booster doses to ensure full protection.

As mentioned in this manuscript, the COVID-19 still uncertain for any kind factors that can be affected on spreading of this virus. However, regarding many sources of COVID-19 study, the further assessment on this factor need to be continue to be sure, that we ready to facing probably in 10years projection of solar minimum phase can be held in same situation for another pandemic.

Read more:

Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19? - Globalization ... - Globalization and Health

FDA Warns: Government-Funded COVID-19 Test Not On Cue – Medtech Insight

May 15, 2024

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

More here:

FDA Warns: Government-Funded COVID-19 Test Not On Cue - Medtech Insight

CDC Faked 99% of Reported COVID-19 Deaths? – Snopes.com

May 15, 2024

Claim:

The Centers for Disease Control and Prevention faked 99% of reported deaths from COVID-19.

On May 14, 2024, a rumor went viral on X, claiming that the Centers for Disease Control and Prevention faked 99% of reported deaths from COVID-19. As of this writing, the post had gained more than 107,500 views, 2,900 comments and 5,400 reactions.

(X user @iluminatibot)

The post linked to an articlefrom a site called Slay News with the headline "CDC Faked 99% of Reported 'Covid Deaths,' Data Shows" from August 2023. It read:

The U.S. Centers for Disease Control and Prevention (CDC) has just quietly published new data that reveals a staggering 99% of reported "Covid deaths" were not actually caused by the virus.

Recent data from the CDC reveals a troubling statistic showing that most recorded fatalities that were blanket-blamed on Covid were actually caused by something else.

According to the CDC's Covid dashboard, just 1.7% of the 324 "Covid deaths" registered in the week ending August 19 had the coronavirus as the primary cause of death.

Alarmingly, the vast majority of people who were labeled as so-called "Covid deaths" actually died of other causes such as cancer and heart disease.

"According to the CDC's own data, 99 percent of 'Covid deaths' have been faked," the article said.

In short, because the viral rumor misrepresents the CDC's data on COVID-19 deaths, we have rated this claim as "False."

According to the CDC's website, for the week ending on Aug. 19, 2023, COVID-19 accounted for 1.6% of all U.S. fatalities. However, that does not imply that 99% of the reported COVID-19 deaths were unrelated to the virus, as the number reflected COVID-19 deaths as a percentage of deaths from all causes.

(www.covid.cdc.gov)

The same claim was debunked by AP News and PolitiFactin 2023. The AP reported that in August 2023 the rumor was spread through online posts citing a Daily Mail article as proof, which was later updated to reflect what the numbers actually showed:

A correction added to the Daily Mail article notes that "an earlier version of this article claimed 99 percent of Covid deaths in the past week were not primarily caused by the virus." It then describes how the actual data was calculated and states that the article has been amended to reflect this. The headline of the article was also updated to read: "Covid to blame for just 1% of weekly deaths from all causes across the US, CDC data shows."

Scott Pauley, a spokesperson for the CDC, told The Associated Press that the Daily Mail article now accurately reflects the agency's data and that the CDC has been in touch with the publication about this issue.

It's not the first time we've investigated a CDC-related rumor. In September 2023, we debunked a claim that the CDC said Americans who received mRNA COVID-19 vaccines were at higher risk of infection from new variants of the virus than those who were unvaccinated. In April 2020 we investigated whether the CDC's guidelines for listing COVID-19 on death certificates in the absence of a test were resulting in a case overcount.

Bergman, Frank. "CDC Faked 99% of Reported 'Covid Deaths,' Data Shows." Slay News, 30 Aug. 2023, https://slaynews.com/news/cdc-faked-99-reported-covid-deaths-data-shows/.

CDC. "COVID Data Tracker." Centers for Disease Control and Prevention, 28 Mar. 2020, https://covid.cdc.gov/covid-data-tracker.

"CDC Data Does Not Show That 99% of COVID-19 Deaths Were Due to Other Causes." AP News, 30 Aug. 2023, https://apnews.com/article/fact-check-covid-deaths-99-percent-cdc-data-828332813362.

O'Rourke, Ciara. "Misinterpretation of COVID-19 Data Leads to Misinformation." @politifact, https://www.politifact.com/factchecks/2023/oct/05/viral-image/misinterpretation-of-cdc-covid-19-data-leads-to-mi/. Accessed 14 May 2024.

Palma, Bethania. "Are CDC Guidelines for Reporting COVID-19 Deaths Inflating Numbers?" Snopes, 20 Apr. 2020, https://www.snopes.com//fact-check/cdc-guidelines-covid19/.

Wrona, Aleksandra. "CDC Says Vaccinated Americans Have Higher Risk of Infection than Unvaccinated?" Snopes, 5 Sept. 2023, https://www.snopes.com//fact-check/cdc-risk-assessment-summary-covid-vaccine/.

View post:

CDC Faked 99% of Reported COVID-19 Deaths? - Snopes.com

Mers outbreak in Saudi Arabia puts health experts on high alert – The Telegraph

May 13, 2024

The first case, a man with underlying health conditions, went to hospital in early April after developing a cough, fever and body aches. He later died from the disease.

But two other men in the same hospital, both aged 60, have also tested positive for the coronavirus sparking a broad contact tracing effort from health officials, to detect further infections before it can spread further. Dozens of people have been tested.

Hospitals can either serve as a source of prevention or amplification of transmission, said Dr Saskia Popescu, an infectious disease epidemiologist at the University of Maryland School of Medicine.

Ive spent a lot of time studying Mers healthcare-transmission cases and using those lessons to strengthen healthcare bioprep and honestly, THIS is why we invest in infection prevention programs, she wrote on X, formerly Twitter.

Mers was first detected in 2012, when it jumped from camels to humans in Saudi Arabia, and it has since spread to 27 other countries. Globally, 2,204 cases and 860 deaths have been reported, according to the WHO the vast majority, more than 80 per cent, have been in Saudi Arabia.

Earlier this year, the country also reported a fatal case in Taif a city 500 miles west of Riyadh, by the Red Sea earlier this year.

There have been several large chains of transmission in healthcare facilities including the largest outbreak outside of the Middle East, in South Korea in 2015. The country confirmed 185 cases and 38 fatalities as the coronavirus swept through 24 hospitals.

While several Mers treatments and vaccines are in clinical development, unlike Covid-19 none have been carried through clinical trials and approved by regulators.

[This is] a good reminder that we dont have any proven antiviral treatments, vaccines or rapid diagnostics for Mers, said Dr Tom Fletcher, an infectious disease specialist at the Liverpool School of Tropical Medicine.

The WHO said the latest cases do not change the overall risk assessment, though it expects that additional cases of Mers-CoV infection will be reported from the Middle East and/or other countries where Mers-CoV is circulating in dromedaries.

The health analytic firm Airfinty, which monitors disease outbreaks globally, said there was a high threat for the city Riyadh.

Mers-CoV [is] still around and still a threat, Prof Peter Horby, director of the Pandemic Sciences Institute at the University of Oxford said on X. [Saudi Arabia] has great experience of detecting and controlling health-care associated MERS transmission other places are less aware and less prepared.

Prof David Heymann, Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine, said there had been no change in epidemiology with these infections.

He added: The index case is not the first case but was likely infected from the first case they are looking for that case now.

Protect yourself and your family by learning more about Global Health Security

More:

Mers outbreak in Saudi Arabia puts health experts on high alert - The Telegraph

A deadly coronavirus has resurfaced in Saudi Arabia, killing at least one patient – Salon

May 13, 2024

On Wednesday, May 8, the World Health Organization (WHO) confirmed an April outbreak of a coronavirus similar to SARS-CoV-2, which causes COVID-19. Four new infections of a coronavirus known as Middle East respiratory syndrome (MERS-CoV) have been reported in Saudi Arabia, according to health officials in that country. At least one of those cases resulted in death.

Because at least two of the MERS-CoV infections involved human-to-human transmission, some researchers are concerned that the outbreak could cause a new pandemic. Despite these fears, the WHO stillassesses the overall risk posed by MERS to be "moderate" both regionally and globally. That is in part because three of the four confirmed cases were all limited to a single hospital in the Saudi Arabian capital of Riyadh. The last infectionoccurred in the city of Taif and involved a patient who had contact with camels. That infection is not believed to be directly connected to the other three.

"The three cases are epidemiologically linked to exposures in a health-care facility in Riyadh, although investigations are ongoing to verify this and understand the route of transmission," the WHO said.

In the one case that became a fatality, the WHO reports that the patient was a 56-year-old male schoolteacher who reported a cough, runny nose, fever and body aches on March 29. He was admitted to an emergency room at a Riyadh hospital on April 4, and two days later was transferred to the Intensive Care Unit isolation and intubated. He had preexisting health conditions that may have contributed to his death, including high blood pressure andchronic renal failure requiring hemodialysis. It is unclear how he was initially exposed to MERS-CoV.

MERS first came to light in 2012, and since then has been responsible for about 940 deaths out of 2,500 cases, giving it a pretty high fatality rate of 36%. There is currently no vaccine for this virus.

See the original post here:

A deadly coronavirus has resurfaced in Saudi Arabia, killing at least one patient - Salon

FLiRT COVID variants are spreading. Scientists share what we know so far. – WTOP

May 13, 2024

More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of so-called "FLiRT" variants, nicknamed for their small but distinctive changes relative to the JN.1 strain. JN.1 was the variant behind this past winter wave of infections.

Watch Video: Marking 4 years since the start of the COVID pandemic

More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of so-called FLiRT variants, nicknamed for their small but distinctive changes relative to the JN.1 strain. JN.1 was the variant behind this past winter wave of infections.

The largest among them, called KP.2 by scientists, has quickly multiplied in recent weeks to become the now-dominant new COVID-19 strain.

According to the Centers for Disease Control and Preventions every-other-week variant estimates, KP.2 and another strain with the same FLiRT mutations, called KP.1.1, together make up a projected 35.3% of infections this week. This is up from 7.1% a month ago.

That means that while KP.2 is proportionally the most predominant variant, it is not causing an increase in infections as transmission of SARS-CoV-2 is low, a CDC spokesperson told CBS News in a statement.

The strain also does not have large amounts of worrying changes, unlike some previously highly-mutated variants that have raised alarm in years past.

However, the swift change in circulating variants has resulted in the Food and Drug Administration this week delaying a key step in its process for picking out the strain to target with this falls COVID-19 vaccines, citing the need for more up-to-date data.

While federal requirements for hospitals to report COVID-19 data to authorities lapsed this month, the CDC says it still has reliable figures from sources like wastewater testing and emergency rooms to continue tracking activity from the virus.

Heres the latest of what we know about COVID-19 variants in the U.S.

According to the latest projections published by the CDC, around 28.2% of COVID-19 cases nationwide are now being caused by a sublineage of the virus called the KP.2 variant.

The next largest variant on the rise is another JN.1 descendant called JN.1.16. That strain has not grown as quickly, only inching up to an estimated 10% of cases this week.

That projection is based on genetic sequences of the virus reported by mostly public health labs, which have dropped significantly in recent weeks alongside the slowdown in cases overall. Other CDC data from wastewater and traveler testing still does not separate out KP.2 from its JN.1 parent.

KP.2 is a closely related descendant of the JN.1 variant from this past winter, which turned out not to be significantly more severe than the variants that were dominant before it, despite its large number of mutations.

So its one that we are watching. Its one that we are monitoring. And again, reiterate the need for continued surveillance of SARS-CoV-2 in people around the world, so that we can monitor this evolution, the World Health Organizations Maria Van Kerkhove told reporters Wednesday.

The nickname FLiRT comes from two distinctive mutations seen in several descendants of the JN.1 variant that have sprung up around the world after its sweep over the winter. Some of the largest strains with FLiRT mutations in the U.S. right now are KP.2 and KP.1.1.

It is essentially just making a word out of the specific amino acid changes in the spike protein F456L + R346T, or phenylalanine (F) to leucine (L) at position 456 and arginine [R] to threonine [T] at position 346, Canadian biologist Ryan Gregory, a professor at the University of Guelph, told CBS News in an email.

Gregory coined this nickname in March, and it gained traction among the variant trackers who have spotted and nicknamed many distinctive changes to the virus during the pandemic. Though unofficial, these nicknames have become commonly used names for a number of variants.

FLiRT won out over another nickname tiLT variants which had been coined by Australian consultant Mike Honey. FLiRT refers to a collection of faster-growing JN.1 offshoots the trackers are keeping an eye on, KP.2 among them.

Basically, pretty much everything right now is a descendant of BA.2.86.1.1 (JN.1) and things are evolving rapidly, so it makes more sense to focus on mutations of interest rather than individual variants for the time being, wrote Gregory.

Unlike some previous highly mutated variants that had raised concerns over potential changes to symptoms in recent years, the JN.1 variant many Americans already likely caught over the winter is closely related to the KP.2 strain now on the rise.

Based on current data there are no indicators that KP.2 would cause more severe illness than other strains, a CDC spokesperson told CBS News.

KP.2s two distinctive so-called FLiRT mutations have also been seen before, in XBB.1.5 variants that were circulating throughout 2023, the spokesperson said.

A draft study from scientists in Japan, released as a preprint that has yet to be peer-reviewed, found that the variant did appear to dodge antibodies better than the JN.1 variant. This increased immune resistance likely explains its rise, the scientists said.

In general, health authorities and experts have downplayed claims that variants were causing different symptoms. Changes to a persons immunity from vaccines and prior infections often play a role in different symptoms, rather than specific mutations.

Mutations happen frequently, but only sometimes change the characteristics of the virus, the CDC says.

The CDC has not made any changes to its current vaccine recommendations, which were last updated in April. But the emergence of these new JN.1 variant descendants like KP.2 might affect what vaccine the FDA picks out for this coming fall and winter.

Most Americans remain eligible to get at least one dose of this past seasons updated COVID-19 vaccine, which CDC data so far suggests was up to 51% effective against emergency room or urgent care visits during a time when JN.1 was on the rise.

CDC will continue to monitor community transmission of the virus and how vaccines perform against this strain, the agency said of KP.2.

Last month, the World Health Organizations experts recommended that vaccine manufacturers produce shots targeted at the JN.1 variant for next season. A panel of the FDAs own vaccine experts were scheduled to weigh that approach for the American vaccine market next week.

However, the agency recently announced it had decided to delay the meeting until June in hopes of buying more time to ensure it picks out a vaccine target that is most appropriate to be used for the strain(s) anticipated to be circulating in the fall.

The FDA, along with its public health partners, carefully monitors trends in the circulating strains of SARS-CoV-2. As has happened since the emergence of COVID-19, we have recently observed shifts in the dominant circulating strains of SARS-CoV-2, an FDA spokesperson told CBS News in a statement.

Pfizer has generated data from research of its vaccines against KP.2, but a company spokesperson said they were currently unable to share the results. A Moderna spokesperson did not respond to a request for comment.

A Novavax spokesperson said they had data showing their vaccine candidate for the fall aimed at JN.1 has good cross-reactivity for KP.2. While Novavaxs vaccine takes longer to make than the mRNA shots from Pfizer and Moderna, the spokesperson said FDAs delay to the meeting will not affect their ability to deliver a shot this fall.

We have manufactured JN.1 consistent with the recommendations and are on track to deliver an updated vaccine this fall, the Novavax spokesperson said.

Go here to read the rest:

FLiRT COVID variants are spreading. Scientists share what we know so far. - WTOP

A Member of Newer Family of ‘FLiRT’ COVID-19 Variants is Dominant Strain In United States – Contagionlive.com

May 13, 2024

Data trends show a new family of variants has arisen, but that hospitalizations and deaths have decreased.

CDC is reporting the KP2 variant is the dominant strain of COVID-19 in terms of cases being reported in the United States, with 25% of all current infections from it.1 This comes from the federal agencys latest reporting week, April 21-27, 2024.

KP2 is included in a newer family of variants, called FLiRTs, named after their mutations.2 According to CDC, another FLiRT variant, KP11, accounts for about 7.5% of cases. Together, they account for 32.5% of all reported cases in the country.1

Additionally, the JN1 strain, which was formerly the dominant strain in the United States is now shown to be 22% of all US cases.1

These newer FLiRT variants have been so named based on the technical names for their mutations, one of which includes the letters F and L, and another of which includes the letters R and T. 3

Table 1. Here is a summary of the variants, reporting the week of April 21-27, 2024.

Table credit: ChatGPT

Hospitalization and Mortality Rates CDCs data does show some positive news in that both hospitalizations and deaths have been trending down. For the reporting week of April 21-27, 2024, there was a total of 727 new hospital admissions of patients confirmed with COVID-19 in all age groups. This is down from the 819 hospitalizations the week before (April 14-April 20.)

In terms of mortality in the US, there were 184 provisional COVID-19 deaths for the week, ending April 27. This is a continuing downward trend from the previous 2 weeks where there was 347 deaths the week ending April 20, and the week before that (week ending April 13), there were 485 deaths.

Table 2. This summarizes the COVID-19 hospitalizations and mortality rates in recent weeks.

Table credit: CHATGPT

Changes in Data Reporting According to CDC, it is important to note that as of May 1, 2024, hospitals were no longer required to report COVID-19 hospital admissions, hospital capacity, or hospital occupancy data to Health and Human Services, through CDCs National Healthcare Safety Network (NHSN). Thus the data going forward could be limited, especially as medical institutions are not obligated to report data.

However, the CDC says it still encourages ongoing, voluntary reporting of hospitalization data. The data voluntarily reported to NHSN after May 1, will be available starting May 10.

References

1.COVID Data Tracker.CDC. Accessed May 6, 2024. https://covid.cdc.gov/covid-data-tracker/#variant-proportions

2. Novak S. New FLiRT Variants Spark Summer COVID Surge Warning. WebMD. April 30, 2024. Accessed May 6. 2024. https://www.webmd.com/covid/news/20240430/new-variant-sparks-summer-covid-surge-warning 3. Ducharme J. What to Know About the FLiRT Variants of COVID-19. Time. April 29, 2024. Accessed May 6. 2024. https://time.com/6972143/covid-19-flirt-variants-kp-2/

View post:

A Member of Newer Family of 'FLiRT' COVID-19 Variants is Dominant Strain In United States - Contagionlive.com

Analysis of Risk Factors for Death in the Coronavirus Disease 2019 (COVID-19) Population: Data Analysis from a … – Cureus

May 13, 2024

Specialty

Please choose I'm not a medical professional. Allergy and Immunology Anatomy Anesthesiology Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health Family Medicine Forensic Medicine Gastroenterology General Practice Genetics Geriatrics Health Policy Hematology HIV/AIDS Hospital-based Medicine I'm not a medical professional. Infectious Disease Integrative/Complementary Medicine Internal Medicine Internal Medicine-Pediatrics Medical Education and Simulation Medical Physics Medical Student Nephrology Neurological Surgery Neurology Nuclear Medicine Nutrition Obstetrics and Gynecology Occupational Health Oncology Ophthalmology Optometry Oral Medicine Orthopaedics Osteopathic Medicine Otolaryngology Pain Management Palliative Care Pathology Pediatrics Pediatric Surgery Physical Medicine and Rehabilitation Plastic Surgery Podiatry Preventive Medicine Psychiatry Psychology Pulmonology Radiation Oncology Radiology Rheumatology Substance Use and Addiction Surgery Therapeutics Trauma Urology Miscellaneous

Excerpt from:

Analysis of Risk Factors for Death in the Coronavirus Disease 2019 (COVID-19) Population: Data Analysis from a ... - Cureus

Page 31«..1020..30313233..4050..»